tirzepatide once weekly for the treatment of obesity journal club in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide leads to weight reduction

Understanding Mounjaro To provide some context, Mounjaro, or tirzepatide, is an innovative medication designed to treat type 2 diabetes and aid in weight management

Purpose-built for physicians Top-dose phentermine/topiramate cost-effective after 5 years for adolescents with obesity Key takeaways: Lifestyle counseling is more cost-effective than anti-obesity medications at 13 months and 2 years for adolescents with obesity

Think of it like this: Novo Nordisk developed semaglutide, got it approved for diabetes under the name Ozempic, then later reformulated it at a higher dose and got separate FDA approval for weight loss under the name Wegovy

Its fat-mobilizing mechanism is complementary to retatrutide rather than redundant

Uneven suspension means inconsistent dosing

2019 Dec 31;14(12):e0227202